Inhibition of Histone Deacetylase Activity Increases Cisplatin Efficacy to Eliminate Metastatic Cells in Pediatric Liver Cancers.
Ruhi GulatiYasmeen FleifilKatherine JenningsAlexander J BondocGreg TiaoJames GellerLubov TimchenkoNikolai TimchenkoPublished in: Cancers (2024)
Our studies demonstrate the synergistic benefits of HDAC inhibition and cisplatin to eliminate metastasis-initiating cells in pediatric liver cancers.